Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

AbundRX vs AskRx

AbundRX
Graded #192

Higher grade

vs+10.5
AskRx
Graded #430

Lower grade

The verdict

AbundRX takes it — 66.3/100 to 55.8/100.

AbundRX grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. AbundRX (Abundant Wellness) is an online medical weight-care platform connecting patients with licensed clinicians for compounded GLP-1 treatment.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueAbundRX +42
66
24
Dose & formulationAskRx +3
64
67
Clinical oversightAskRx +3
79
82
Labs & monitoringAbundRX +1
53
52
FulfillmentAskRx +14
74
88
Contract termsAbundRX +35
55
20
AbundRX · left barAskRx · right bar

The numbers

MetricAbundRXAskRx
WeighScore66.3/10055.8/100
GradeCC
Scorecard rank#192#430
Semaglutide$179/mo (compounded)$349/mo (all doses, brand-name)
Tirzepatide$279/mo (compounded)$299/mo (2.5 mg dose, brand-name)
CoverageCoverage not publishedAll 50 states
Brand-name accessCompounded onlyYes
Oral / sublingualInjection onlyInjection only
AbundRX

Graded #192 · C

Strengths

  • Two clear compounded GLP-1 pathways with transparent pricing — semaglutide $179/mo and tirzepatide $279/mo
  • Fast, free shipping and a simple few-minute online health assessment
  • Provider-guided care connecting patients with licensed US clinicians
  • Publishes Terms, Privacy, and Refund policies

Where it loses points

  • Claims LegitScript certification in text but displays no verifiable seal or listing
  • Compounded medications are not FDA-approved (the site discloses this) — not brand Wegovy, Ozempic, Zepbound, or Mounjaro
  • Compounding pharmacy not named; no HIPAA notice found; state availability not published
  • Heavily hedged marketing language ('may include', 'helping connect patients') — reads like a lead-generation platform
AskRx

Graded #430 · C

Strengths

  • Prescribes only FDA-approved brand-name GLP-1s, no compounded drugs
  • LegitScript approved and HIPAA compliant
  • Board-certified physicians trained in obesity medicine
  • Transparent dose-based pricing published on site
  • Available in all 50 states

Where it loses points

  • Cash-pay model; medication cost billed separately by the pharmacy
  • Does not dispense medication itself, so fulfillment depends on third-party pharmacies
  • No compounded lower-cost alternative offered
  • Specific list of supported states is not published

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard